“Africa is struggling to turn local discoveries into drugs and other health care inventions,” according to studies published in Science and BMC International Health and Human Rights, Nature News reports (Nordling, 12/12).
‘Complacency Is Dangerous’ In Global HIV/AIDS Fight: A Lancet Editorial is critical of UNAIDS Executive Director Michel Sidibe’s statement in the annual UNAIDS reportÂ that “We have halted and begun to reverse the epidemic.” The editorial states, “These words, from the head of a U.N. agency, are reckless and premature, and…
Also In Global Health News: Cholera In Haiti; Food In Ghana; Health Care Access In Afghanistan; Violence Against Women In Somalia; Male Circumcision Study
CDC Report Documents Cholera’s Spread In Haiti Haiti’s cholera outbreak has spread across the country and infected more than 91,000 people, while more than 2,000 people have died as a result, the CDC said in its Morbidity and Mortality Weekly Report, which was published on Wednesday, the Los Angeles Times…
The New York Times examines the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health program, which gave a total of $450 million to 43 research projects over five years. “On drawing attention to ways that lives might be saved through scientific advances, I’d give us an A,” Bill Gates, co-founder of the foundation, said of the program in an interview with the newspaper. “But I thought some would be saving lives by now, and it’ll be more like in 10 years from now,” Gates said.
On Monday, a campaign started in Burkina Faso to “inoculate tens of millions of West Africans with a new vaccine in what scientists hope will be the beginning of the end of ravaging meningitis epidemics” across the continent, the New York Times reports. Burkina Faso marks the first country in a drive aimed at “bringing the disease under control and saving an estimated 150,000 lives by 2015 in a belt of 25 nations that girds the continent,” according to the newspaper (Dugger, 12/4).
India, EU Trade Agreement Will Not Restrict Ability For India Pharmaceutical Firms To Export Generic Drugs, Official Says
“India and the European Union (EU) have agreed that the comprehensive bilateral trade agreement being negotiated by the two will not result in an intellectual property regime that restricts the ability of Indian pharmaceutical firms to export generic or off-patent drugs by being far more stringent than the TRIPS [Trade-Related Aspects of International Property Rights] regime of the World Trade Organization,” LiveMint.com reports in an article that describes recent debates over the agreement. “The two sides agreed to this at a meeting between Indian trade minister Anand Sharma and his counterpart in the European Commission (EC), Karel De Gucht, at Brussels on 29 November, said a senior commerce ministry official on condition of anonymity,” the news service reports.
The Problem With A ‘Robo Budget’: In a post on “The Hill’s Congress Blog,” Senator Patrick Leahy, (D-Vt.), writes about the recent defeat of the omnibus bill, calling the passage of a continuing resolution a “robo budget” that is a “disservice.” According to Leahy: “The Omnibus would have funded global…
The WHO on Tuesday will begin an International Classification of Traditional Medicine (ICTM) project in an effort to offer “a unified, global set of statistical standards across diverse traditional approaches to health care,” Science’s “ScienceInsider” blog reports (Normile, 12/6). “We recognize that the use of traditional medicine is widespread. For…
New research published in BMC Pregnancy and Childbirth notes some of the “serious short- and long-term health issues” associated with preterm births and identifies steps that can be taken to reduce the number of stillbirths and premature births worldwide, United Press International reports. Each year, 13 million babies are born preterm and there are 3.2 million stillbirths, according to the research. “Neonatal deaths account for more than 42 percent of mortality in children under age 5 â€“ a rise from 37 percent in the year 2000, the report said,” UPI writes (2/22).
New Pneumonia, Meningitis Vaccine Approved In U.S.; Pfizer, GAVI Will Lower Price In Developing Countries
The FDA approved Prevnar 13 â€“ a “new version of a blockbuster vaccine that fights pneumonia, meningitis and other infections” â€“ for use in children up to age five in the U.S., Reuters reports (Richwine, 2/24).